Evidence map›Paper›PMID 41674652›Full record

ArticleFrontiers in aging neuroscience2025

Leveraging object detection for early diagnosis of neurodegenerative diseases through radiomic analysis.

Wenhong Zhi, Zhiguang Liu, Linjian Huang, Miaoran Li, Xin Xu, Zhijian Xi

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenhong ZhiDepartment of Neurology, Xuzhou Central Hospital Affiliated to Southeast University, Xuzhou, China.
Zhiguang LiuDepartment of Neurology, Xuzhou Central Hospital Affiliated to Southeast University, Xuzhou, China.
Linjian HuangDepartment of Neurology, Xuzhou Central Hospital Affiliated to Southeast University, Xuzhou, China.
Miaoran LiDepartment of Neurology, Xuzhou Central Hospital Affiliated to Southeast University, Xuzhou, China.
Xin XuDepartment of Neurology, Xuzhou Central Hospital Affiliated to Southeast University, Xuzhou, China.
Zhijian XiDepartment of Neurology, Xuzhou Central Hospital Affiliated to Southeast University, Xuzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Early diagnosis of neurodegenerative diseases remains a formidable challenge in modern neuroimaging, due to subtle and heterogeneous brain deterioration patterns in early disease stages. Integrating artificial intelligence and radiomic analysis has emerged as a powerful paradigm for non-invasive biomarker discovery and precision diagnostics. In alignment with trends emphasizing cross-modality analysis, interpretability, and demographic generalization, this study introduces a novel approach leveraging object detection and disentangled representation learning to improve early detection sensitivity and reliability. Traditional radiomics frameworks often suffer from limited generalizability, rigid feature engineering, and confounding variability from age, imaging protocol, or anatomical variations, undermining clinical robustness. Methods: Our method addresses these limitations through a three-pronged strategy. We construct a hybrid representation framework separating age-related morphometric changes from disease-specific alterations. We introduce NeuroFact-Net, a dual-path variational encoder-decoder architecture supervised along anatomical and diagnostic axes, enhancing interpretability and facilitating trajectory analysis. Wedevise a Causal Disease-Aware Alignment (CDAA) strategy imposing population-level invariance and disease-specific consistency using contrastive learning, adversarial subgroup confusion, and maximum mean discrepancy constraints. Results and discussion: Experiments across multi-site MRl and PET datasets demonstrate superior diagnostic accuracy, domain transferability, and latent biomarker interpretability, validating its potential for clinical deployment in early-stage screening. This work contributes a scalable, interpretable, and causally grounded computational framework aligned with Al-enhanced neuroimaging advancements.

Indexed as

disentangled representationdomain alignmentearly diagnosisneurodegenerative diseasesradiomic analysis

Identifiers

PMID41674652
PMCPMC12886338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.